MCL1 and neoplasm: Alternatively, miR-29 serves as a tumor suppressor in cholangiocarcinoma by targeting myeloid leukemia 1 (MCL-1) and in acute myeloid leukemia by orchestrating DNA methyltransferases, thereby restoring the expression of tumor suppressor genes through DNA hypomethylation [64].